News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Four Penn Startups Make The Philadelphia Business Journal’s PHL Inno List of 2024 Startups to Watch
Baleena, BlueWhale Bio, Treeswift and Verismo were all recognized.
Penn health system profits support medical research and teaching over past decade
Penn was highlighted in the Philadelphia Inquirer for investing $2 billion in profits from its health system into medical research and physician support over the past decade.
PCI Showcases Penn’s Neuroscience Innovation During JP Morgan Healthcare Conference
The program was well attended by professionals from across the globe in pharma, medtech and biotech industries and offered an incredible opportunity for networking and connection.
Temperature Controlled Material Developed for Robotic Gripper Applications
When the SMP is in a soft state, it allows the gripper to make good contact with the object and conform to objects with irregular shapes or surfaces.
PCI Recognized on Technical.ly’s List of Philadelphia’s Biggest Tech Moments of 2023
In the article, Technical.ly highlights that Penn affiliated startups attracted over $1 billion in investment capital in 2023.
Penn Nobel-Prize Winners Receive Warm Welcome in Sweden
Karikó and Weissman were celebrated at several days of ceremonies and festivities in Sweden, two months after first learning the news.
Serpex Acquired by Maverix Medical
Serpex Medical leverages the power of steerable instruments to enable greater precision and access to improve the diagnosis and treatment of lung cancer.
PCI’s 8th Annual Celebration of Innovation Honors Research and Commercialization Accomplishments at Penn
On December 5th, 2023, PCI hosted its annual Celebration of Innovation, where special awards were presented for exceptional commercialization accomplishments and to celebrate Penn innovators.
Penn Engineering Researchers Invent Origami-Inspired Microbots
The goal of this innovative technology is to use the microrobots to assist in repairing peripheral nerves.
More than 260,000 Penn Medicine patients have agreed to share their DNA for research via Penn Medicine BioBank
By obtaining samples from a wide-cross section of humanity, researchers are able to cross-reference participants’ DNA with their health records and identify genetic variants for a range of diseases.